Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H25N5O |
Molecular Weight | 327.424 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCCC[C@]1([H])C3=C(CCC4=C(N=C(N)N=C34)N5CCNCC5)O2
InChI
InChIKey=DJKJVWJQAVGLHJ-WCQYABFASA-N
InChI=1S/C18H25N5O/c19-18-21-16-12(17(22-18)23-9-7-20-8-10-23)5-6-14-15(16)11-3-1-2-4-13(11)24-14/h11,13,20H,1-10H2,(H2,19,21,22)/t11-,13+/m0/s1
Molecular Formula | C18H25N5O |
Molecular Weight | 327.424 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18983139Curator's Comment: Description was created based on several sources, including http://www.fasebj.org/content/23/1_Supplement/760.8.short
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18983139
Curator's Comment: Description was created based on several sources, including http://www.fasebj.org/content/23/1_Supplement/760.8.short
A-987306 is a new histamine H(4) antagonist. A-987306 is potent in H(4) receptor binding assays (rat H(4), K(i) = 3.4 nM, human H(4) K(i) = 5.8 nM) and demonstrated potent functional antagonism in vitro at human, rat, and mouse H(4) receptors in cell-based FLIPR assays. A-987306 also demonstrated H(4) antagonism in vivo in mice, blocking H(4)-agonist induced scratch responses, and showed anti-inflammatory activity in mice in a peritonitis model. Most interesting was the high potency and efficacy of this compound in blocking pain responses, where it showed an ED(50) of 42 umol/kg (ip) in a rat post-carrageenan thermal hyperalgesia model of inflammatory pain. A-987306 inhibited the scratching response (IC50 = 0.4 umoles/kg, i.p.) with (85%) inhibition seen at 30 umoles/kg, i.p. A-987306 is a potent and selective H4R antagonist with robust antipruritic activity and is a useful tool for further exploration of the role of H4R receptors in vivo.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3759 |
5.8 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18983139 |
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:57:40 GMT 2023
by
admin
on
Sat Dec 16 10:57:40 GMT 2023
|
Record UNII |
6BVK16R925
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70148488
Created by
admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
|
PRIMARY | |||
|
44538833
Created by
admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
|
PRIMARY | |||
|
1082954-71-9
Created by
admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
|
PRIMARY | |||
|
6BVK16R925
Created by
admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |